Research output per year
Research output per year
Search results
-
2024
Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria
Kulasekararaj, A., Lanza, F., Arvanitakis, A., Langemeijer, S., Chonat, S., Tombak, A., Hanes, V., Cao, J., Miller, M. J., Colbert, A., Shander, B., Mytych, D. T., Chow, V. & Henary, H., 2024 Nov, In: American Journal of Hematology. 99, 11, p. 2108-2117 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Primary prophylaxis implementation and long-term joint outcomes in Swedish haemophilia A patients
Arvanitakis, A., Jepsen, C., Andersson, N. G., Baghaei, F. & Astermark, J., 2024, In: Haemophilia. 30, 3, p. 671-677Research output: Contribution to journal › Article › peer-review
Open Access -
Sicklecellsjukdom - vanliga och farliga komplikationer
Björkman, H., Fager Ferrari, M., Arvanitakis, A. & Kjellander, C., 2024, In: Läkartidningen. 121, 23174.Research output: Contribution to journal › Article › peer-review
-
2023
Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health-related quality of life in patients with severe haemophilia A
Arvanitakis, A., Holme, P. A., Berntorp, E. & Astermark, J., 2023 Jul, In: Haemophilia. 29, 4, p. 1032-1038 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2022
Clinical outcome and adherence rate in Scandinavian patients with intermediate-intensity prophylaxis before and after the switch of standard half-life FVIII products to BAY 81–8973
Arvanitakis, A., Holme, P. A., Berntorp, E. & Astermark, J., 2022, In: Haemophilia. 28, 2, p. 223-229Research output: Contribution to journal › Article › peer-review
Open Access -
2021
A comparison of MyPKFiT and WAPPS-Hemo as dosing tools for optimizing prophylaxis in patients with severe haemophilia A treated with Octocog alfa
Arvanitakis, A., Berntorp, E. & Astermark, J., 2021 May 1, In: Haemophilia. 27, 3, p. 417-424 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2013
Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.
Askmyr, M., Ågerstam, H., Hansen, N., Gordon, S., Arvanitakis, A., Rissler, M., Juliusson, G., Richter, J., Järås, M. & Fioretos, T., 2013, In: Blood. 121, 18, p. 3709-3713Research output: Contribution to journal › Article › peer-review